<!doctype html><html lang=en><head><meta charset=utf-8><meta name=description content="Klinik aus [[Akinese]], [[Rigor]], [[Ruhetremor]], [[Posturale Instabilität]] durch [[DOPamin]]-Mangel
 Epidemiologie:: 40-60 Jahre, Prävalenz 0.2% Ätiologie:: [[M. Parkinson]] (>75%), Monogenetische Defekte, [[Atypische Parkinson-Syndrome]], Sekundäre Parkinson-Syndrome Pathophysiologie:: [[DOPamin]]↓ an [[Striatum]]-Rezeptoren → Disinhibition↓ → Motorik-Hemmung↑ → Bradykinese Symptome:: ==[[Akinese]], [[Rigor]], [[Ruhetremor]], [[Posturale Instabilität]]== Diagnostik  [[Untersuchung Neurologie]]: Wendeschrittzahl↑, Bradydiadochokinese, Pendeltest einseitig↓, Zahnradphänomen beim Durchbewegen, Froment-Manöver, langsamer Kopffalltest, Retro-/Antepulsion, unerschöpflicher Gabellareflex [[Bildgebung]]: Standard [[cCT]]/[[cMRT]] zum Ausschluss atypisch/sekundär L-Dopa-Test / Apomorphin-Test: Ansprechen Hinweis auf [[M."><meta property="og:title" content="Parkinson-Syndrom"><meta property="og:description" content="Klinik aus [[Akinese]], [[Rigor]], [[Ruhetremor]], [[Posturale Instabilität]] durch [[DOPamin]]-Mangel
 Epidemiologie:: 40-60 Jahre, Prävalenz 0.2% Ätiologie:: [[M. Parkinson]] (>75%), Monogenetische Defekte, [[Atypische Parkinson-Syndrome]], Sekundäre Parkinson-Syndrome Pathophysiologie:: [[DOPamin]]↓ an [[Striatum]]-Rezeptoren → Disinhibition↓ → Motorik-Hemmung↑ → Bradykinese Symptome:: ==[[Akinese]], [[Rigor]], [[Ruhetremor]], [[Posturale Instabilität]]== Diagnostik  [[Untersuchung Neurologie]]: Wendeschrittzahl↑, Bradydiadochokinese, Pendeltest einseitig↓, Zahnradphänomen beim Durchbewegen, Froment-Manöver, langsamer Kopffalltest, Retro-/Antepulsion, unerschöpflicher Gabellareflex [[Bildgebung]]: Standard [[cCT]]/[[cMRT]] zum Ausschluss atypisch/sekundär L-Dopa-Test / Apomorphin-Test: Ansprechen Hinweis auf [[M."><meta property="og:type" content="website"><meta property="og:image" content="https://test.vincentweber.neticon.png"><meta property="og:url" content="https://test.vincentweber.net/Parkinson-Syndrom/"><meta property="og:width" content="200"><meta property="og:height" content="200"><meta name=twitter:card content="summary"><meta name=twitter:title content="Parkinson-Syndrom"><meta name=twitter:description content="Klinik aus [[Akinese]], [[Rigor]], [[Ruhetremor]], [[Posturale Instabilität]] durch [[DOPamin]]-Mangel
 Epidemiologie:: 40-60 Jahre, Prävalenz 0.2% Ätiologie:: [[M. Parkinson]] (>75%), Monogenetische Defekte, [[Atypische Parkinson-Syndrome]], Sekundäre Parkinson-Syndrome Pathophysiologie:: [[DOPamin]]↓ an [[Striatum]]-Rezeptoren → Disinhibition↓ → Motorik-Hemmung↑ → Bradykinese Symptome:: ==[[Akinese]], [[Rigor]], [[Ruhetremor]], [[Posturale Instabilität]]== Diagnostik  [[Untersuchung Neurologie]]: Wendeschrittzahl↑, Bradydiadochokinese, Pendeltest einseitig↓, Zahnradphänomen beim Durchbewegen, Froment-Manöver, langsamer Kopffalltest, Retro-/Antepulsion, unerschöpflicher Gabellareflex [[Bildgebung]]: Standard [[cCT]]/[[cMRT]] zum Ausschluss atypisch/sekundär L-Dopa-Test / Apomorphin-Test: Ansprechen Hinweis auf [[M."><meta name=twitter:image content="https://test.vincentweber.neticon.png"><meta name=twitter:site content="vncntwbr"><title>Parkinson-Syndrom</title><meta name=viewport content="width=device-width,initial-scale=1"><link rel="shortcut icon" type=image/png href=https://test.vincentweber.net/icon.png><link href=https://test.vincentweber.net/styles.cfbac90e55cfef247c47edcca25506aa.min.css rel=stylesheet><link href=https://test.vincentweber.net/styles/_light_syntax.86a48a52faebeaaf42158b72922b1c90.min.css rel=stylesheet id=theme-link><script src=https://test.vincentweber.net/js/darkmode.46cdcb28adbf5d5aad580a2ecf303596.min.js></script>
<script src=https://test.vincentweber.net/js/util.a0ccf91e1937fe761a74da4946452710.min.js></script>
<link rel=preload href=https://cdn.jsdelivr.net/npm/katex@0.15.1/dist/katex.min.css as=style onload='this.onload=null,this.rel="stylesheet"' integrity=sha384-R4558gYOUz8mP9YWpZJjofhk+zx0AS11p36HnD2ZKj/6JR5z27gSSULCNHIRReVs crossorigin=anonymous><script defer src=https://cdn.jsdelivr.net/npm/katex@0.15.1/dist/katex.min.js integrity=sha384-z1fJDqw8ZApjGO3/unPWUPsIymfsJmyrDVWC8Tv/a1HeOtGmkwNd/7xUS0Xcnvsx crossorigin=anonymous></script>
<script defer src=https://cdn.jsdelivr.net/npm/katex@0.15.1/dist/contrib/auto-render.min.js integrity=sha384-+XBljXPPiv+OzfbB3cVmLHf4hdUFHlWNZN5spNQ7rmHTXpd7WvJum6fIACpNNfIR crossorigin=anonymous></script>
<script defer src=https://cdn.jsdelivr.net/npm/katex@0.16.2/dist/contrib/copy-tex.min.js integrity=sha384-ww/583aHhxWkz5DEVn6OKtNiIaLi2iBRNZXfJRiY1Ai7tnJ9UXpEsyvOITVpTl4A crossorigin=anonymous></script>
<script async src=https://unpkg.com/@floating-ui/core@0.7.3></script>
<script async src=https://unpkg.com/@floating-ui/dom@0.5.4></script>
<script async src=https://test.vincentweber.net/js/popover.aa9bc99c7c38d3ae9538f218f1416adb.min.js></script>
<script defer src=https://test.vincentweber.net/js/code-title.60f1f75ed725d525c91d24e437dab0b1.min.js></script>
<script defer src=https://test.vincentweber.net/js/clipboard.2913da76d3cb21c5deaa4bae7da38c9f.min.js></script>
<script defer src=https://test.vincentweber.net/js/callouts.7723cac461d613d118ee8bb8216b9838.min.js></script>
<script>const SEARCH_ENABLED=!1,LATEX_ENABLED=!0,PRODUCTION=!0,BASE_URL="https://test.vincentweber.net",fetchData=Promise.all([fetch("https://test.vincentweber.net/indices/linkIndex.ae89de7d7564a525f136270ebe928f19.min.json").then(e=>e.json()).then(e=>({index:e.index,links:e.links})),fetch("https://test.vincentweber.net/indices/contentIndex.836f3fc38eef45df9d61f163694470de.min.json").then(e=>e.json())]).then(([{index:e,links:t},n])=>({index:e,links:t,content:n})),render=()=>{const e=new URL(BASE_URL),t=e.pathname,n=window.location.pathname,s=t==n;addCopyButtons(),addTitleToCodeBlocks(),addCollapsibleCallouts(),initPopover("https://test.vincentweber.net",!0);const o=document.getElementById("footer");if(o){const e=document.getElementById("graph-container");if(!e)return requestAnimationFrame(render);e.textContent="";const t=s&&!1;drawGraph("https://test.vincentweber.net",t,[{"/moc":"#4388cc"}],t?{centerForce:1,depth:-1,enableDrag:!0,enableLegend:!1,enableZoom:!0,fontSize:.5,linkDistance:1,opacityScale:3,repelForce:1,scale:1.4}:{centerForce:1,depth:1,enableDrag:!0,enableLegend:!1,enableZoom:!0,fontSize:.6,linkDistance:1,opacityScale:3,repelForce:2,scale:1.2})}var i=document.getElementsByClassName("mermaid");i.length>0&&import("https://unpkg.com/mermaid@9/dist/mermaid.esm.min.mjs").then(e=>{e.default.init()});function a(n){const e=n.target,t=e.className.split(" "),s=t.includes("broken"),o=t.includes("internal-link");plausible("Link Click",{props:{href:e.href,broken:s,internal:o,graph:!1}})}const r=document.querySelectorAll("a");for(link of r)link.className.includes("root-title")&&link.addEventListener("click",a,{once:!0})},init=(e=document)=>{addCopyButtons(),addTitleToCodeBlocks(),renderMathInElement(e.body,{delimiters:[{left:"$$",right:"$$",display:!0},{left:"$",right:"$",display:!1}],macros:{'’':"'"},throwOnError:!1})}</script><script type=module>
    import { attachSPARouting } from "https:\/\/test.vincentweber.net\/js\/router.d6fe6bd821db9ea97f9aeefae814d8e7.min.js"
    attachSPARouting(init, render)
  </script><script defer data-domain=test.vincentweber.net src=https://plausible.io/js/script.js></script>
<script>window.plausible=window.plausible||function(){(window.plausible.q=window.plausible.q||[]).push(arguments)}</script></head><body><div id=search-container><div id=search-space><input autocomplete=off id=search-bar name=search type=text aria-label=Search placeholder="Search for something..."><div id=results-container></div></div></div><script src=https://cdn.jsdelivr.net/npm/flexsearch@0.7.21/dist/flexsearch.bundle.js integrity="sha256-i3A0NZGkhsKjVMzFxv3ksk0DZh3aXqu0l49Bbh0MdjE=" crossorigin=anonymous defer></script>
<script defer src=https://test.vincentweber.net/js/full-text-search.e6e2e0c213187ca0c703d6e2c7a77fcd.min.js></script><div class=singlePage><header><h1 id=page-title><a class=root-title href=https://test.vincentweber.net>Vincent's Notes</a></h1><div class=spacer></div><div id=search-icon><p>Search</p><svg tabindex="0" aria-labelledby="title desc" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 19.9 19.7"><title id="title">Search Icon</title><desc id="desc">Icon to open search</desc><g class="search-path" fill="none"><path stroke-linecap="square" d="M18.5 18.3l-5.4-5.4"/><circle cx="8" cy="8" r="7"/></g></svg></div><div class=darkmode><input class=toggle id=darkmode-toggle type=checkbox tabindex=-1>
<label id=toggle-label-light for=darkmode-toggle tabindex=-1><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" id="dayIcon" viewBox="0 0 35 35" style="enable-background:new 0 0 35 35"><title>Light Mode</title><path d="M6 17.5C6 16.672 5.328 16 4.5 16h-3C.672 16 0 16.672.0 17.5S.672 19 1.5 19h3C5.328 19 6 18.328 6 17.5zM7.5 26c-.414.0-.789.168-1.061.439l-2 2C4.168 28.711 4 29.086 4 29.5 4 30.328 4.671 31 5.5 31c.414.0.789-.168 1.06-.44l2-2C8.832 28.289 9 27.914 9 27.5 9 26.672 8.329 26 7.5 26zm10-20C18.329 6 19 5.328 19 4.5v-3C19 .672 18.329.0 17.5.0S16 .672 16 1.5v3C16 5.328 16.671 6 17.5 6zm10 3c.414.0.789-.168 1.06-.439l2-2C30.832 6.289 31 5.914 31 5.5 31 4.672 30.329 4 29.5 4c-.414.0-.789.168-1.061.44l-2 2C26.168 6.711 26 7.086 26 7.5 26 8.328 26.671 9 27.5 9zM6.439 8.561C6.711 8.832 7.086 9 7.5 9 8.328 9 9 8.328 9 7.5c0-.414-.168-.789-.439-1.061l-2-2C6.289 4.168 5.914 4 5.5 4 4.672 4 4 4.672 4 5.5c0 .414.168.789.439 1.06l2 2.001zM33.5 16h-3c-.828.0-1.5.672-1.5 1.5s.672 1.5 1.5 1.5h3c.828.0 1.5-.672 1.5-1.5S34.328 16 33.5 16zM28.561 26.439C28.289 26.168 27.914 26 27.5 26c-.828.0-1.5.672-1.5 1.5.0.414.168.789.439 1.06l2 2C28.711 30.832 29.086 31 29.5 31c.828.0 1.5-.672 1.5-1.5.0-.414-.168-.789-.439-1.061l-2-2zM17.5 29c-.829.0-1.5.672-1.5 1.5v3c0 .828.671 1.5 1.5 1.5s1.5-.672 1.5-1.5v-3C19 29.672 18.329 29 17.5 29zm0-22C11.71 7 7 11.71 7 17.5S11.71 28 17.5 28 28 23.29 28 17.5 23.29 7 17.5 7zm0 18c-4.136.0-7.5-3.364-7.5-7.5s3.364-7.5 7.5-7.5 7.5 3.364 7.5 7.5S21.636 25 17.5 25z"/></svg></label><label id=toggle-label-dark for=darkmode-toggle tabindex=-1><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" id="nightIcon" viewBox="0 0 100 100" style="enable-background='new 0 0 100 100'"><title>Dark Mode</title><path d="M96.76 66.458c-.853-.852-2.15-1.064-3.23-.534-6.063 2.991-12.858 4.571-19.655 4.571C62.022 70.495 50.88 65.88 42.5 57.5 29.043 44.043 25.658 23.536 34.076 6.47c.532-1.08.318-2.379-.534-3.23-.851-.852-2.15-1.064-3.23-.534-4.918 2.427-9.375 5.619-13.246 9.491-9.447 9.447-14.65 22.008-14.65 35.369.0 13.36 5.203 25.921 14.65 35.368s22.008 14.65 35.368 14.65c13.361.0 25.921-5.203 35.369-14.65 3.872-3.871 7.064-8.328 9.491-13.246C97.826 68.608 97.611 67.309 96.76 66.458z"/></svg></label></div></header><article><h1>Parkinson-Syndrom</h1><p class=meta>Last updated
Feb 10, 2023
<a href=https://github.com/diabolicvincent-git/quartz/tree/hugo/content/Parkinson-Syndrom.md rel=noopener>Edit Source</a></p><ul class=tags><li><a href=https://test.vincentweber.net/tags/Modul/m15/>Modul m15</a></li><li><a href=https://test.vincentweber.net/tags/Fach/Neurologie/>Fach neurologie</a></li><li><a href=https://test.vincentweber.net/tags/Art/Pathologie/>Art pathologie</a></li></ul><aside class=mainTOC><details><summary>Table of Contents</summary><nav id=TableOfContents><ol><li><ol><li><a href=#parkinson>Parkinson</a></li></ol></li><li><a href=#pathomechanismus-m-parkinson>Pathomechanismus ([[M. Parkinson]])</a></li><li><a href=#symptome>Symptome</a></li><li><a href=#diagnostik>Diagnostik</a><ol><li><a href=#dd>DD</a></li></ol></li><li><a href=#therapie>Therapie</a><ol><li><a href=#medikamentöse-standardtherapie>Medikamentöse Standardtherapie</a></li><li><a href=#weitere-optionen>Weitere Optionen</a></li></ol></li></ol></nav></details></aside><p>Klinik aus <a class="internal-link broken">Akinese</a>, <a class="internal-link broken">Rigor</a>, <a class="internal-link broken">Ruhetremor</a>, <a class="internal-link broken">Posturale Instabilität</a> durch <a href=/DOPamin rel=noopener class=internal-link data-src=/DOPamin>DOPamin</a>-Mangel</p><ul><li><strong>Epidemiologie</strong>:: 40-60 Jahre, Prävalenz 0.2%</li><li><strong>Ätiologie</strong>:: <a href=/M rel=noopener class=internal-link data-src=/M>M. Parkinson</a> (>75%), Monogenetische Defekte, <a class="internal-link broken">Atypische Parkinson-Syndrome</a>, Sekundäre Parkinson-Syndrome</li><li><strong>Pathophysiologie</strong>:: <a href=/DOPamin rel=noopener class=internal-link data-src=/DOPamin>DOPamin</a>↓ an <a class="internal-link broken">Striatum</a>-Rezeptoren → Disinhibition↓ → Motorik-Hemmung↑ → Bradykinese</li><li><strong>Symptome</strong>:: ==<a class="internal-link broken">Akinese</a>, <a class="internal-link broken">Rigor</a>, <a class="internal-link broken">Ruhetremor</a>, <a class="internal-link broken">Posturale Instabilität</a>==</li><li><strong>Diagnostik</strong><ul><li><strong><a href=/Untersuchung-Neurologie rel=noopener class=internal-link data-src=/Untersuchung-Neurologie>Untersuchung Neurologie</a>:</strong> Wendeschrittzahl↑, Bradydiadochokinese, Pendeltest einseitig↓, Zahnradphänomen beim Durchbewegen, Froment-Manöver, langsamer Kopffalltest, Retro-/Antepulsion, unerschöpflicher Gabellareflex</li><li><strong><a href=/Bildgebung rel=noopener class=internal-link data-src=/Bildgebung>Bildgebung</a>:</strong> Standard <a class="internal-link broken">cCT</a>/<a class="internal-link broken">cMRT</a> zum Ausschluss atypisch/sekundär</li><li><strong>L-Dopa-Test / Apomorphin-Test:</strong> Ansprechen Hinweis auf <a href=/M rel=noopener class=internal-link data-src=/M>M. Parkinson</a></li></ul></li><li><strong>Therapie</strong>:: s. <a href=/M rel=noopener class=internal-link data-src=/M>M. Parkinson</a></li></ul><a href=#parkinson><h3 id=parkinson><span class=hanchor arialabel=Anchor># </span>Parkinson</h3></a><ul><li><strong>Parkinson-Syndrom</strong>:: Klinisches Bild aus <em>Akinesie, Rigor, Ruhetremor, Posturale Instabilität</em></li><li><strong><a href=/M rel=noopener class=internal-link data-src=/M>M. Parkinson</a></strong>:: Häufigste Form mit >75% (<em>Idiopathisches Parkinson-Syndrom</em>)</li><li><a href=/Neurodegenerative-Erkrankungen rel=noopener class=internal-link data-src=/Neurodegenerative-Erkrankungen>Neurodegenerative Erkrankungen</a> dopaminerger <a href=/Neuron rel=noopener class=internal-link data-src=/Neuron>Neuron</a>e in der <a class="internal-link broken">Substantia nigra</a> (<a href=/Synuclein rel=noopener class=internal-link data-src=/Synuclein>Synuclein</a>-Aggregate)</li></ul><a href=#pathomechanismus-m-parkinson><h2 id=pathomechanismus-m-parkinson><span class=hanchor arialabel=Anchor># </span>Pathomechanismus (<a href=/M rel=noopener class=internal-link data-src=/M>M. Parkinson</a>)</h2></a><ul><li>Aggregation von <a href=/Synuclein rel=noopener class=internal-link data-src=/Synuclein>Synuclein</a> → Untergang dopaminerger <a href=/Neuron rel=noopener class=internal-link data-src=/Neuron>Neuron</a> v.a. in den <a href=/Basalganglien rel=noopener class=internal-link data-src=/Basalganglien>Basalganglien</a><ul><li>Aggregate (&ldquo;Lewy-Körperchen&rdquo;) sind hyalin, eosinophil</li></ul></li><li>Ausbleibende dopaminerge Disinhibition → Bradykinesie</li><li>Progression der Degeneration in andere Hirnareale, häufig Übergang zu <a href=/Demenz rel=noopener class=internal-link data-src=/Demenz>Demenz</a></li></ul><a href=#symptome><h2 id=symptome><span class=hanchor arialabel=Anchor># </span>Symptome</h2></a><ul><li><strong>Initialsymptomatik</strong>:: Obstipation, Hyposmie, REM-Schlaf-Verhaltensstörung, reduziertes Mitschwingen der Arme</li><li><strong>Kardinalsymptome</strong><ul><li><mark>Bradykinesie / Akinesie</mark></li><li><mark>Rigor</mark></li><li>==Ruhe<a href=/Tremor rel=noopener class=internal-link data-src=/Tremor>Tremor</a>==</li><li><mark>Posturale Instabilität</mark> (Unsicherheit beim Stehen)</li></ul></li><li>Psychische Symptome: <a href=/Affektive-St%C3%B6rung rel=noopener class=internal-link data-src=/Affektive-St%C3%B6rung>Affektive Störung</a>, Halluzinationen, Psychose</li><li><strong>Diagnosesicherung</strong> (≥3 der folgenden Kriterien)<ul><li>Unilateraler Beginn</li><li>Persistierende Asymmetrie der Symptome</li><li>Gutes Ansprechen auf L-DOPA</li><li>Klinischer Verlauf >10 Jahre</li></ul></li></ul><a href=#diagnostik><h2 id=diagnostik><span class=hanchor arialabel=Anchor># </span>Diagnostik</h2></a><ul><li><strong>L-DOPA Response</strong> akut (200 mg) oder chronisch (500-1000 mg/d)</li><li><a href=/EEG rel=noopener class=internal-link data-src=/EEG>EEG</a>, cMRT, cCT, <a href=/Liquordiagnostik rel=noopener class=internal-link data-src=/Liquordiagnostik>Liquordiagnostik</a></li><li>Nuklearmedizinische Untersuchung des <a class="internal-link broken">Striatum</a> (Projektionsort dopaminerger <a href=/Neuron rel=noopener class=internal-link data-src=/Neuron>Neuron</a>)</li></ul><a href=#dd><h3 id=dd><span class=hanchor arialabel=Anchor># </span>DD</h3></a><ul><li>Essentieller <a href=/Tremor rel=noopener class=internal-link data-src=/Tremor>Tremor</a> (i.d.R. bilateral), autosomal-dominant vererbt</li><li>Intentionstremor (<a href=/Kleinhirnsyndrom rel=noopener class=internal-link data-src=/Kleinhirnsyndrom>Kleinhirnsyndrom</a>)</li><li>Vaskuläre Genese (z.B. Normaldruck-<a href=/Hydrocephalus rel=noopener class=internal-link data-src=/Hydrocephalus>Hydrocephalus</a>)</li><li>Medikamentös-toxische Genese (z.B. <a href=/M rel=noopener class=internal-link data-src=/M>M. Wilson</a>, <a href=/Antiemetika rel=noopener class=internal-link data-src=/Antiemetika>Antiemetika</a>, <a href=/Antipsychotika rel=noopener class=internal-link data-src=/Antipsychotika>Antipsychotika</a>, Calcium-Antagonisten, Valproat)</li></ul><a href=#therapie><h2 id=therapie><span class=hanchor arialabel=Anchor># </span>Therapie</h2></a><blockquote><p>Keine Kausale Therapie!</p></blockquote><a href=#medikamentöse-standardtherapie><h3 id=medikamentöse-standardtherapie><span class=hanchor arialabel=Anchor># </span>Medikamentöse Standardtherapie</h3></a><ul><li><strong><mark>Dopaminagonsten</mark></strong><ul><li>Längere HWZ als <a href=/DOPamin rel=noopener class=internal-link data-src=/DOPamin>DOPamin</a>, jedoch geringere Wirkung an D2-<a href=/Rezeptor rel=noopener class=internal-link data-src=/Rezeptor>Rezeptor</a> (hohe Dosen nötig)</li><li><a href=/UAW rel=noopener class=internal-link data-src=/UAW>UAW</a>: Schlafattacken (Cave: Fahrtüchtigkeit)</li></ul></li><li><strong><mark>L-DOPA</mark></strong> (Synthesevorstufe des <a href=/DOPamin rel=noopener class=internal-link data-src=/DOPamin>DOPamin</a>)<ul><li>L-DOPA ist <a href=/Blut-Hirn-Schranke rel=noopener class=internal-link data-src=/Blut-Hirn-Schranke>Blut-Hirn-Schranke</a>-gängig, im Gegensatz zu <a href=/DOPamin rel=noopener class=internal-link data-src=/DOPamin>DOPamin</a> selbst</li><li>In Kombination mit DOPA-Decarboxylase-Inhibitoren, um verfrühte Aktivierung zu <a href=/DOPamin rel=noopener class=internal-link data-src=/DOPamin>DOPamin</a> in der Peripherie zu verhindern</li></ul></li><li><strong>COMT-Inhibitoren</strong> und <strong><a href=/MAO-Hemmer rel=noopener class=internal-link data-src=/MAO-Hemmer>MAO-Hemmer</a></strong> verhindern <a href=/Katecholamine rel=noopener class=internal-link data-src=/Katecholamine>Katecholamine</a>-Abbau</li><li><strong><a href=/Anticholinergika rel=noopener class=internal-link data-src=/Anticholinergika>Anticholinergika</a></strong><ul><li>Verhindern Überdominanz cholinerger <a href=/Neuron rel=noopener class=internal-link data-src=/Neuron>Neuron</a> im Striatum bei Wegfall der dopaminergen</li><li>Cave: Kein <a href=/Atropin rel=noopener class=internal-link data-src=/Atropin>Atropin</a> o.ä. sondern gut <a href=/Blut-Hirn-Schranke rel=noopener class=internal-link data-src=/Blut-Hirn-Schranke>Blut-Hirn-Schranke</a>-gängige Präparate, um <a href=/Parasympathikus rel=noopener class=internal-link data-src=/Parasympathikus>Parasympathikus</a>-<a href=/UAW rel=noopener class=internal-link data-src=/UAW>UAW</a> zu reduzieren</li></ul></li><li><strong><a href=/Glutamat rel=noopener class=internal-link data-src=/Glutamat>Glutamat</a>-<a href=/Rezeptor rel=noopener class=internal-link data-src=/Rezeptor>Rezeptor</a>-Antagonisten</strong> (NMDA)</li></ul><a href=#weitere-optionen><h3 id=weitere-optionen><span class=hanchor arialabel=Anchor># </span>Weitere Optionen</h3></a><ul><li>Apomorphin-/Duodopa-Pumpen bei Versagen oraler Therapie und zur Mitigation des <em>Wearing-Off-Phänomens</em> (kurze Wirkdauer von L-DOPA)</li><li>ggf. Tiefe Hirnstimulation (elektrische Blockade des hyperaktiven <a class="internal-link broken">Ncl. subthalamicus</a> und <a class="internal-link broken">Pallidum</a>)</li></ul></article><hr><div class=page-end id=footer><div class=backlinks-container><h3>Backlinks</h3><ul class=backlinks><li><a href=/Apoptose/ data-ctx=Parkinson-Syndrom data-src=/Apoptose class=internal-link>Apoptose</a></li><li><a href=/Atypische-Antipsychotika/ data-ctx=Parkinson-Syndrom data-src=/Atypische-Antipsychotika class=internal-link>Atypische Antipsychotika</a></li><li><a href=/Clozapin/ data-ctx=Parkinson-Syndrom data-src=/Clozapin class=internal-link>Clozapin</a></li><li><a href=/Delir/ data-ctx=Parkinson-Syndrom data-src=/Delir class=internal-link>Delir</a></li><li><a href=/Demenz/ data-ctx=Parkinson-Syndrom data-src=/Demenz class=internal-link>Demenz</a></li><li><a href=/Depression/ data-ctx=Parkinson-Syndrom data-src=/Depression class=internal-link>Depression</a></li><li><a href=/Dysarthrie/ data-ctx=Parkinson-Syndrom data-src=/Dysarthrie class=internal-link>Dysarthrie</a></li><li><a href=/Dysphagie/ data-ctx=Parkinson-Syndrom data-src=/Dysphagie class=internal-link>Dysphagie</a></li><li><a href=/Dysphorie/ data-ctx=Parkinson-Syndrom data-src=/Dysphorie class=internal-link>Dysphorie</a></li><li><a href=/Gangst%C3%B6rungen/ data-ctx=Parkinson-Syndrom data-src=/Gangst%C3%B6rungen class=internal-link>Gangstörungen</a></li><li><a href=/IMPP-Arzneistoffe/ data-ctx=Parkinson-Syndrom data-src=/IMPP-Arzneistoffe class=internal-link>IMPP-Arzneistoffe</a></li><li><a href=/Ileus/ data-ctx=Parkinson-Syndrom data-src=/Ileus class=internal-link>Ileus</a></li><li><a href=/KI/ data-ctx=Parkinson-Syndrom data-src=/KI class=internal-link>KI</a></li><li><a href=/Lewy-Body-Demenz/ data-ctx=Parkinson-Syndrom data-src=/Lewy-Body-Demenz class=internal-link>Lewy-Body-Demenz</a></li><li><a href=/M.-Parkinson/ data-ctx=Parkinson-Syndrom data-src=/M.-Parkinson class=internal-link>M. Parkinson</a></li><li><a href=/Neurologie/ data-ctx=Parkinson-Syndrom data-src=/Neurologie class=internal-link>Neurologie</a></li><li><a href=/Phenylketonurie/ data-ctx=Parkinson-Syndrom data-src=/Phenylketonurie class=internal-link>Phenylketonurie</a></li><li><a href=/QT-Zeit-verl%C3%A4ngernde-Medikamente/ data-ctx=Parkinson-Syndrom data-src=/QT-Zeit-verl%C3%A4ngernde-Medikamente class=internal-link>QT-Zeit-verlängernde Medikamente</a></li><li><a href=/Serotonin/ data-ctx=Parkinson-Syndrom data-src=/Serotonin class=internal-link>Serotonin</a></li><li><a href=/Synkope/ data-ctx=Parkinson-Syndrom data-src=/Synkope class=internal-link>Synkope</a></li><li><a href=/Synuclein/ data-ctx=Parkinson-Syndrom data-src=/Synuclein class=internal-link>Synuclein</a></li><li><a href=/Tremor/ data-ctx=Parkinson-Syndrom data-src=/Tremor class=internal-link>Tremor</a></li><li><a href=/Urindiagnostik/ data-ctx=Parkinson-Syndrom data-src=/Urindiagnostik class=internal-link>Urindiagnostik</a></li></ul></div><div><script async src=https://cdn.jsdelivr.net/npm/d3@6.7.0/dist/d3.min.js integrity="sha256-+7jaYCp29O1JusNWHaYtgUn6EhuP0VaFuswhNV06MyI=" crossorigin=anonymous></script><h3>Interactive Graph</h3><div id=graph-container></div><style>:root{--g-node:var(--secondary);--g-node-active:var(--primary);--g-node-inactive:var(--visited);--g-link:var(--outlinegray);--g-link-active:#5a7282}</style><script src=https://test.vincentweber.net/js/graph.6579af7b10c818dbd2ca038702db0224.js></script></div></div><div id=contact_buttons><footer><p>Made by Vincent Weber using <a href=https://github.com/jackyzha0/quartz>Quartz</a>, © 2023</p><ul><li><a href=https://test.vincentweber.net>Home</a></li><li><a href=https://twitter.com/vncntwbr>Twitter</a></li></ul></footer></div></div></body></html>